Erik A M Verschuuren
Overview
Explore the profile of Erik A M Verschuuren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
932
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu S, Westra J, Hu S, Verschuuren E, van Kempen L, van Baarle D, et al.
Front Transplant
. 2025 Jan;
3:1508419.
PMID: 39744543
The acute rejection (AR) diagnosis depends on transbronchial biopsy, which is semi-invasive and not easily performed Our study used the Nanostring gene expression technology on PBMCs obtained from lung transplant...
2.
Nossent E, Nossent G, Meijboom L, Verschuuren E, Gan C, Aman J, et al.
Am J Respir Crit Care Med
. 2024 Sep;
210(11):1370-1373.
PMID: 39288369
No abstract available.
3.
Van De Wauwer C, van Suylen V, Zhang Z, Verschuuren E, van der Bij W, Gan C, et al.
Front Transplant
. 2024 Jul;
1:988950.
PMID: 38994392
lung perfusion (EVLP) is a technique for reconditioning and evaluating lungs. However, the use of EVLP for logistical reasons is still under discussion. In this retrospective study, all EVLPs performed...
4.
Swarte J, Zhang S, Nieuwenhuis L, Gacesa R, Knobbe T, de Meijer V, et al.
Gut
. 2024 Jul;
73(10):1650-1661.
PMID: 38955400
Objective: Gut microbiome composition is associated with multiple diseases, but relatively little is known about its relationship with long-term outcome measures. While gut dysbiosis has been linked to mortality risk...
5.
Zhang S, Swarte J, Gacesa R, Knobbe T, Kremer D, Jansen B, et al.
mSystems
. 2024 May;
9(6):e0131223.
PMID: 38712927
Gut dysbiosis has been associated with impaired outcomes in liver and kidney transplant recipients, but the gut microbiome of lung transplant recipients has not been extensively explored. We assessed the...
6.
van Dommelen J, Grootjans H, Uijtendaal E, Ruigrok D, Luijk B, van Luin M, et al.
Clin Pharmacokinet
. 2024 Apr;
63(5):683-693.
PMID: 38581638
Background And Objective: High variability in tacrolimus pharmacokinetics directly after lung transplantation (LuTx) may increase the risk for acute kidney injury (AKI) and transplant rejection. The primary objective was to...
7.
Luong M, Nakamachi Y, Silveira F, Morrissey C, Danziger-Isakov L, Verschuuren E, et al.
Transpl Infect Dis
. 2024 Feb;
26(3):e14251.
PMID: 38351512
Purpose: Antimicrobial misuse contributes to antimicrobial resistance in thoracic transplant (TTx) and mechanical circulatory support (MCS) recipients. This study uses a modified Delphi method to define the expected appropriate antimicrobial...
8.
Kremer D, Berger S, Verschuuren E, Bakker S, Knoester M
Kidney Int Rep
. 2024 Feb;
9(2):491-494.
PMID: 38344716
No abstract available.
9.
Hoek R, Liu S, GeurtsvanKessel C, Verschuuren E, Vonk J, Hellemons M, et al.
Front Immunol
. 2024 Jan;
14:1254659.
PMID: 38239369
Background: Data on cellular response and the decay of antibodies and T cells in time are scarce in lung transplant recipients (LTRs). Additionally, the development and durability of humoral and...
10.
van Gemert J, Ravensbergen S, Verschuuren E, Kerstjens H, Willemse B, van Ingen J, et al.
Transplant Rev (Orlando)
. 2023 Oct;
37(4):100800.
PMID: 37832509
Background: There is lack of consensus on non-tuberculous mycobacteria pulmonary disease (NTM-PD) treatment regimen and duration in patient listed for lung transplantation (LTx). We conducted a systematic review on treatment...